Altamira Therapeutics (CYTO) shares were down about 5% in Wednesday's premarket activity after it priced a public offering of 5.6 million common shares and two tranches of pre-funded warrants to purchase up to 11.2 million shares at $0.72 per share or warrant.
The offering is expected to close Thursday.
The company intends to use net proceeds from the offering for general corporate purposes.
Price: 0.7520, Change: -0.04, Percent Change: -4.79
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments